Analysts putting the weights on merck........re keytruda....
I keep repeating this but those last patent approvals are vital in these
combos......
https://www.google.com/url?sa=t&source=web&cd=1&ved=2ahUKEwig1Zbwx63gAhVGX30KHZHfA14QFjAAegQIBhAB&url=http%3A%2F%2Fwww.pmlive.com%2Fpharma_news%2Fanalysts_look_beyond_keytruda_in_mercks_future_1277223&usg=AOvVaw0_VtqlGf3MBswLskJ74nIx
if keytruda and efti prove compatible and positive it will extend keytruda's
patent period in certain cancer treatments by some 8-10 years....
Given they are making some $2.2B per quarter from keytruda alone
it's not hard to work out the possibilities if "EFTI" plays its part.
Immunotherapy Market value, page-14
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.3¢ |
Change
0.008(2.46%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 32.5¢ | 30.5¢ | $699.8K | 2.252M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 201580 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 339159 | 40 |
View Market Depth
| Last trade - 14.40pm 25/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
